Crinetics Pharmaceuticals, Inc. (CRNX) Financials
Key financial figures for Crinetics Pharmaceuticals, Inc. (Q2 2026).
- Revenue
- $25M
- Net Income
- -$121M
- EPS
- $-1.14
- Total Assets
- $1.3B
- Operating Cash Flow
- -$94M
Full income statement, balance sheet, and cash flow for Crinetics Pharmaceuticals, Inc. on SentiSense.